Drugs for Neglected Diseases initiative 221d ago

📖 Our new report is out! Open science in a closed world: lessons and opportunities for securing openness and equitable access in R&D collaborations. Drawing on more than 20 years of experience developing treatments for neglected populations, this report explores how open and collaborative science—together with a pro-access approach to intellectual property—can: ✅ accelerate innovation ✅ promote knowledge sharing ✅ ensure that health technologies are affordable and accessible for all who need them. It provides a practical framework for embedding openness and equitable access across the innovation lifecycle and offers actionable recommendations for governments, funders, academia, and industry. 🌍 At a time of shrinking R&D budgets, geopolitical tensions, new technological advances in biomedicine, and renewed calls for stronger and more self-sufficient innovation ecosystems, especially in low- and middle-income countries, the report makes a powerful case for transforming aspirations for greater openness and equitable access into concrete changes in policy and practice. Watch the video to see open science in action with our drug discovery partner, Icahn School of Medicine at Mount Sinai. 🔗 Read the full report: https://bit.ly/47KnOB5 💬 Join the conversation: Share your reflections using #MakeScienceOpen and tag @DNDi. ------------------ The Drugs for Neglected Diseases initiative (DNDi) is an international non-profit developing safe, effective, and affordable treatments for the most neglected patients. https://dndi.org